Financial Statements
Bayer Group Consolidated Statements of Recognized Income and Expense
| 1st Quarter 2006 | 1st Quarter 2007 | |
| € million | ||
| Changes in fair values of derivatives designated as hedges and available-for-sale financial assets, recognized in stockholders’ equity | 9 | 1 |
| Changes in actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits, recognized in stockholders’ equity | 805 | 331 |
| Exchange differences on translation of operations outside the euro zone, recognized in stockholders’ equity | (144) | 36 |
| Deferred taxes on valuation adjustments offset directly against stockholders’ equity | (315) | (134) |
| Changes due to changes in scope of consolidation | - | 31 |
| Valuation adjustments recognized directly in stockholders’ equity | 355 | 265 |
| Income after taxes | 597 | 2,810 |
| Total income and expense recognized in the financial statements | 952 | 3,075 |
| of which attributable to minority interest | (5) | 2 |
| of which attributable to Bayer AG stockholders | 957 | 3,073 |



Overview of Sales, Earnings and Financial Position
Statements of Recognized Income and Expense
Bayer Links

Bookmark this page
E-mail this page
Advanced Search

